A study to evaluate organ level uptake repeatability of 124I AT-01 for systemic amyloidosis (AT01-001)

The research company Attralus, Inc is conducting the clinical trial A Study to Evaluate Organ Level Uptake Repeatability of 124I AT-01 in Subjects With Systemic Amyloidosis (AT01-001).

This study is designed to assess the repeatability of organ-specific quantitation of radiotracer uptake following Positron Emission Tomography/Computed Tomography (PET/CT) imaging of AT- 01 in subjects with amyloid light chain (AL) or amyloid transthyretin (ATTR) systemic amyloidosis.

It is planned to include 20 participants.

Actual study start date is November 30, 2021. The researchers expect to complete the study by August 30, 2022.

Further details can be found here https://ichgcp.net/clinical-trials-registry/NCT05235269.